Sandipan Chakraborty

Sandipan Chakraborty practices at Baystate Medical Center in Springfield, Massachusetts, part of Baystate Health.

Sandipan Chakraborty's NPI, 1568815686, was assigned on July 14, 2016. Sandipan Chakraborty holds Massachusetts license 1015028.

Sandipan Chakraborty's primary practice is Baystate Medical Center, at 759 Chestnut Street, Springfield, MA 01199 in Hampden County. The practice phone is (413) 794-0000.

Sandipan Chakraborty's primary practice is Baystate Medical Center in Springfield, Massachusetts, part of Baystate Health. Sandipan Chakraborty is also affiliated with UMass Memorial Medical Center - University Campus. The medical group on file is UMass Memorial Medical Group. Dmand AI also links Sandipan Chakraborty to 1 more hospital, 4 medical groups and 2 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Sandipan Chakraborty practices, 5 sites in all. Vendor and product names are available with a free account.

Internal medicine is Sandipan Chakraborty's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Sandipan Chakraborty is licensed in Massachusetts.

CMS data shows 953 Medicare services from Sandipan Chakraborty across 6 procedure codes in 2024, for 515 Medicare patients. Medicare paid $85,471 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 515 Medicare patients who saw Sandipan Chakraborty in 2024. The largest group is 75 to 84, with 186 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 33% are also on Medicaid. Their average risk score is 2.17, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Sandipan Chakraborty's median patient age at 70, with 62% women.

In 2024, Sandipan Chakraborty wrote 429 Medicare Part D claims for 225 patients. 85% of them were for generic drugs. CMS names the drug for 138 of them, across 8 drugs with 11 or more claims each, at $14,795 in total drug cost. In 2023, CMS named 96 claims across 6 drugs.

Sandipan Chakraborty accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 162 papers to Sandipan Chakraborty, published from 2010 to 2025. 2020 was the busiest year, with 22. The most frequent topics are Molecular Dynamics Simulation, Molecular Docking Simulation and Models, Molecular. Sandipan Chakraborty has published most often in Indian J Cancer. Sandipan Chakraborty's most frequent co-authors are Adrija Hajra, Raktim Kumar Ghosh, MD and Carl J. Lavie, MD.

CMS Open Payments shows 1 general payment to Sandipan Chakraborty from 1 drug or device company in 2019. Food and beverage make up the largest share, 100% of the total. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) paid the most, $26.